Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks

February 4, 2025
Mizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocksMizuho’s Jared Holz on Merck and Pfizer Q4 results, 2025 outlook for Big Pharma stocks
Share This

Jared Holz, Mizuho Securities America healthcare sector strategist, joins ‘Squawk Box’ to break down the quarterly earnings results of Merck and Pfizer, 2025 outlook for pharmaceutical stocks, and more.

Latest Mizuho News

Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

August 10, 2026
Are rising AI costs squeezing Shopify's margins?

Are rising AI costs squeezing Shopify's margins?

August 5, 2026
Mizuho’s Bellinger on Walmart: Gig network of delivery drivers is underappreciated

Mizuho’s Bellinger on Walmart: Gig network of delivery drivers is underappreciated

July 27, 2026

Mizuho news from around the globe

back-to-top-blue